Alpha Tau to Participate at Jefferies Global Healthcare Conference in London
Alpha Tau (NASDAQ: DRTS) said CFO Raphi Levy will participate at the Jefferies Global Healthcare Conference in London on November 18–19, 2025.
Mr. Levy will take part in 1x1 investor meetings; investors should contact their Jefferies representative to schedule meetings.
Alpha Tau (NASDAQ: DRTS) ha dichiarato che il CFO Raphi Levy parteciperà al Jefferies Global Healthcare Conference a Londra il 18–19 novembre 2025.
Il signor Levy parteciperà a riunioni 1x1 con gli investitori; gli investitori dovrebbero contattare il loro rappresentante Jefferies per fissare gli incontri.
Alpha Tau (NASDAQ: DRTS) dijo que el CFO Raphi Levy participará en la Conferencia Global de Cuidado de la Salud de Jefferies en Londres los 18–19 de noviembre de 2025.
El señor Levy participará en reuniones 1x1 con inversionistas; los inversionistas deben ponerse en contacto con su representante de Jefferies para programar reuniones.
Alpha Tau (NASDAQ: DRTS)의 CFO Raphi Levy가 런던에서 열리는 제프리스 글로벌 헬스케어 컨퍼런스에 2025년 11월 18–19일에 참석한다고 밝혔다.
Levy 씨는 일대일 투자자 미팅에 참여할 예정이며; 투자자들은 회의 일정을 잡기 위해 Jefferies 담당자에게 연락해야 한다.
Alpha Tau (NASDAQ: DRTS) annonce que le directeur financier Raphi Levy participera au Jefferies Global Healthcare Conference à Londres les 18–19 novembre 2025.
M. Levy participera à des réunions investisseurs 1x1; les investisseurs devraient contacter leur représentant Jefferies pour programmer des réunions.
Alpha Tau (NASDAQ: DRTS) sagte, dass CFO Raphi Levy an der Jefferies Global Healthcare Conference in London am 18.–19. November 2025 teilnehmen wird.
Herr Levy wird an 1x1-Investorengesprächen teilnehmen; Investoren sollten ihren Jefferies-Ansprechpartner kontaktieren, um Meetings zu vereinbaren.
Alpha Tau (NASDAQ: DRTS) صرّحت بأن المدير المالي رافي ليڤي سيشارك في مؤتمر Jefferies العالمي للرعاية الصحية في لندن في 18–19 نوفمبر 2025.
سيشارك السيد ليڤي في اجتماعات المستثمرين 1x1; يجب على المستثمرين التواصل مع ممثل Jefferies الخاص بهم لترتيب الاجتماعات.
- None.
- None.
JERUSALEM, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today announced that CFO Raphi Levy will participate at the Jefferies Global Healthcare Conference in London on November 18-19, 2025.
| Event: | Jefferies Global Healthcare Conference |
| Format: | 1X1 Investor meetings |
| Date: | November 18-19, 2025 |
| Location: | London |
Mr. Levy will be available for 1x1 investor meetings. Please reach out to your Jefferies representative to schedule.
About Alpha Tau Medical Ltd.
Founded in 2016, Alpha Tau is an Israeli oncology therapeutics company that focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors. The technology was initially developed by Prof. Itzhak Kelson and Prof. Yona Keisari from Tel Aviv University.
About Alpha DaRT®
Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) is designed to enable highly potent and conformal alpha-irradiation of solid tumors by intratumoral delivery of radium-224 impregnated sources. When the radium decays, its short-lived daughters are released from the sources and disperse while emitting high-energy alpha particles with the goal of destroying the tumor. Since the alpha-emitting atoms diffuse only a short distance, Alpha DaRT aims to mainly affect the tumor, and to spare the healthy tissue around it.
Investor Relations Contact: